Hydromer, Inc. announced that during it's last fiscal quarter, ending on March 31st 2012, it had entered into license agreements with three separate Chinese medical device manufacturers.
Under the terms of these agreements, each Chinese company is licensed to use certain proprietary Hydromer medical coatings on medical devices, such as intraocular lens injection nozzles, tissue culture dishes and rods, and various intravenous catheters.
These Chinese medical device companies will make their Hydromer coated devices available for their Chinese and international clients.
"We are delighted with our new Chinese relationships and are proud to have our innovative Hydromer medical coating technologies contribute to the growing Chinese medical device market sector," said Martin von Dyck, executive vice president of Hydromer, Inc. "Each of these Chinese companies is using different Hydromer medical coating technologies that are formulated for their respective device material selections and coated device performance requirements."
Hydromer, Inc. is a bio-technology-based company involved in the research and development, manufacture, contract coating and commercialization of specialized polymer and hydrogel products for medical device, animal health, cosmetic, personal care and industrial uses. These technologies include Hydromer lubricious / anti-microbial / anti-thrombogenic / cell anti-mitosis / cell growth enhancing coatings for the medical marketplace.
Hydromer signs agreement with Chinese companies to use its Hydromer medical coatings
Published May 18, 2012
Related Breaking News
- 43rd Annual Waterborne Symposium Announces Line-up
- CPI Unveils Survey Data of Polyurethanes Industry at 2015 Polyurethanes Technical Conference
- Sun Chemical Launches its Series of Pearlescent Pigments for Exterior Coatings
- Sika AG: Schenker-Winkler Holding Announces Challenge of Certain Decisions of Shareholders Meeting
Related Paint & Coatings Manufacturer News